New insider activity at Varex Imaging ( (VREX) ) has taken place on August 15, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Jay Kunkel recently sold 3,000 shares of Varex Imaging stock, generating a total of $31,470 from the transaction.
Recent Updates on VREX stock
Varex Imaging Corporation recently reported its Q3 earnings, showcasing a mixed performance with revenue exceeding guidance at $203 million, driven by strong industrial segment growth and better-than-expected medical revenue in China. Despite these positives, the company faced challenges with a 4% decline in Medical segment revenue and increased operating expenses due to a $94 million goodwill impairment charge. The firm successfully reduced its debt by repaying $200 million in convertible notes, enhancing its financial structure. Analyst Anderson Schock from B. Riley raised the price target for Varex Imaging, citing reduced tariff pressures and improved 2025 guidance as key reasons for the adjustment. The company remains optimistic about future growth, projecting a 3% sales increase for fiscal year 2025, with anticipated Q4 revenues between $210 million and $230 million.
Spark’s Take on VREX Stock
According to Spark, TipRanks’ AI Analyst, VREX is a Neutral.
Varex Imaging’s overall stock score reflects significant financial challenges, with declining revenues and profitability being the most impactful factors. Despite strong technical indicators suggesting short-term bullish momentum, the negative valuation metrics and mixed earnings call results highlight ongoing risks. The company’s ability to address these financial and operational challenges will be crucial for future performance.
To see Spark’s full report on VREX stock, click here.
More about Varex Imaging
YTD Price Performance: -25.19%
Average Trading Volume: 441,401
Technical Sentiment Signal: Hold
Current Market Cap: $447.4M